Drug profile · INN
ezetimibe
APO-EZETIMIBE
ezetimibe (APO-EZETIMIBE) is a niemann-pick c1-like protein 1 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — ezetimibe
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 10
- Programs
- 14
- Data quality
- 0.89
Quick answer
ezetimibe (APO-EZETIMIBE) is a niemann-pick c1-like protein 1 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Niemann-Pick C1-like protein 1 inhibitor
Primary target: NPC1-like intracellular cholesterol transporter 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
| PMDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related patents
-
US 12404227
Methods of making bempedoic acid and compositions of the same
granted -
US 12398087
Methods of making bempedoic acid and compositions of the same
granted -
US 11926584
Methods of making bempedoic acid and compositions of the same
granted -
US 11760714
Methods of making bempedoic acid and compositions of the same
granted -
US 11744816
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
granted -
US 11613511
Methods of making bempedoic acid and compositions of the same
granted -
US 10912751
Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
granted -
US 10905736
Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism
granted -
US 9095515
Ezetimibe compositions
granted -
US 7335799
Hydroxyl compounds and compositions for cholesterol management and related uses
granted
Frequently asked questions
What is ezetimibe?
ezetimibe (APO-EZETIMIBE) is a niemann-pick c1-like protein 1 inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ezetimibe?
APO-EZETIMIBE is a marketed brand name for ezetimibe. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ezetimibe?
ezetimibe has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.